Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.0082 | 0.9 |
mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.0085 | 0.9 |
mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.034 | 0.9 |
mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.0081 | 0.9 |